BDBM50166298 (2S)-2-(4-chloro-3-(1-(6-chlorobenzo[d]isoxazol-3-yl)-2-methyl-5-(trifluoromethoxy)-1H-indol-3-yloxy)phenoxy)propanoic acid::(S)-2-{4-Chloro-3-[1-(6-chloro-benzo[d]isoxazol-3-yl)-2-methyl-5-trifluoromethoxy-1H-indol-3-ylmethyl]-phenoxy}-propionic acid::CHEMBL363805

SMILES: C[C@H](Oc1ccc(Cl)c(Oc2c(C)n(-c3noc4cc(Cl)ccc34)c3ccc(OC(F)(F)F)cc23)c1)C(O)=O

InChI Key: InChIKey=NOWYXMPKECMLMR-ZDUSSCGKSA-N

Data: 2 IC50  2 EC50

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 50166298   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Peroxisome proliferator-activated receptor (Homo sapiens (Human))	BDBM50166298 ((2S)-2-(4-chloro-3-(1-(6-chlorobenzo[d]isoxazol-3-...) Show SMILES C[C@H](Oc1ccc(Cl)c(Oc2c(C)n(-c3noc4cc(Cl)ccc34)c3ccc(OC(F)(F)F)cc23)c1)C(O)=O |r,wU:1.0,(28.69,2.15,;28.21,.68,;26.71,.36,;25.68,1.51,;26.15,2.97,;25.11,4.12,;23.61,3.79,;22.58,4.93,;23.14,2.33,;21.64,2.01,;21.16,.55,;22.08,-.71,;23.62,-.71,;21.17,-1.96,;21.64,-3.43,;20.75,-4.67,;21.65,-5.92,;23.11,-5.44,;24.44,-6.21,;25.77,-5.44,;27.1,-6.21,;25.76,-3.9,;24.44,-3.14,;23.11,-3.9,;19.69,-1.48,;18.35,-2.26,;17.02,-1.48,;17.02,.06,;15.69,.83,;15.69,2.37,;15.67,3.91,;17.23,2.38,;14.15,2.36,;18.35,.83,;19.69,.07,;24.17,1.18,;29.24,-.46,;30.75,-.14,;28.77,-1.93,)| Show InChI InChI=1S/C26H17Cl2F3N2O6/c1-12-23(37-22-11-15(4-7-19(22)28)36-13(2)25(34)35)18-10-16(38-26(29,30)31)5-8-20(18)33(12)24-17-6-3-14(27)9-21(17)39-32-24/h3-11,13H,1-2H3,(H,34,35)/t13-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	5	n/a	n/a	n/a	n/a	n/a	n/a
Merck Research Laboratories Curated by ChEMBL					Assay Description Inhibition of human peroxisome proliferator activated receptor gamma binding				Bioorg Med Chem Lett 15: 2437-40 (2005) Article DOI: 10.1016/j.bmcl.2005.03.092 BindingDB Entry DOI: 10.7270/Q2CF9PM8
					More data for this Ligand-Target Pair
Peroxisome proliferator-activated receptor (Homo sapiens (Human))	BDBM50166298 ((2S)-2-(4-chloro-3-(1-(6-chlorobenzo[d]isoxazol-3-...) Show SMILES C[C@H](Oc1ccc(Cl)c(Oc2c(C)n(-c3noc4cc(Cl)ccc34)c3ccc(OC(F)(F)F)cc23)c1)C(O)=O |r,wU:1.0,(28.69,2.15,;28.21,.68,;26.71,.36,;25.68,1.51,;26.15,2.97,;25.11,4.12,;23.61,3.79,;22.58,4.93,;23.14,2.33,;21.64,2.01,;21.16,.55,;22.08,-.71,;23.62,-.71,;21.17,-1.96,;21.64,-3.43,;20.75,-4.67,;21.65,-5.92,;23.11,-5.44,;24.44,-6.21,;25.77,-5.44,;27.1,-6.21,;25.76,-3.9,;24.44,-3.14,;23.11,-3.9,;19.69,-1.48,;18.35,-2.26,;17.02,-1.48,;17.02,.06,;15.69,.83,;15.69,2.37,;15.67,3.91,;17.23,2.38,;14.15,2.36,;18.35,.83,;19.69,.07,;24.17,1.18,;29.24,-.46,;30.75,-.14,;28.77,-1.93,)| Show InChI InChI=1S/C26H17Cl2F3N2O6/c1-12-23(37-22-11-15(4-7-19(22)28)36-13(2)25(34)35)18-10-16(38-26(29,30)31)5-8-20(18)33(12)24-17-6-3-14(27)9-21(17)39-32-24/h3-11,13H,1-2H3,(H,34,35)/t13-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	n/a	n/a	3	n/a	n/a	n/a	n/a
Merck Research Laboratories Curated by ChEMBL					Assay Description Agonist activity at human recombinant PPARgamma expressed in COS1 cells coexpressing GAL4 assessed as transcriptional activity after 48 hrs by lucife...				J Med Chem 52: 3846-54 (2009) Article DOI: 10.1021/jm900097m BindingDB Entry DOI: 10.7270/Q2GF0TDR
					More data for this Ligand-Target Pair
Peroxisome proliferator-activated receptor (Homo sapiens (Human))	BDBM50166298 ((2S)-2-(4-chloro-3-(1-(6-chlorobenzo[d]isoxazol-3-...) Show SMILES C[C@H](Oc1ccc(Cl)c(Oc2c(C)n(-c3noc4cc(Cl)ccc34)c3ccc(OC(F)(F)F)cc23)c1)C(O)=O |r,wU:1.0,(28.69,2.15,;28.21,.68,;26.71,.36,;25.68,1.51,;26.15,2.97,;25.11,4.12,;23.61,3.79,;22.58,4.93,;23.14,2.33,;21.64,2.01,;21.16,.55,;22.08,-.71,;23.62,-.71,;21.17,-1.96,;21.64,-3.43,;20.75,-4.67,;21.65,-5.92,;23.11,-5.44,;24.44,-6.21,;25.77,-5.44,;27.1,-6.21,;25.76,-3.9,;24.44,-3.14,;23.11,-3.9,;19.69,-1.48,;18.35,-2.26,;17.02,-1.48,;17.02,.06,;15.69,.83,;15.69,2.37,;15.67,3.91,;17.23,2.38,;14.15,2.36,;18.35,.83,;19.69,.07,;24.17,1.18,;29.24,-.46,;30.75,-.14,;28.77,-1.93,)| Show InChI InChI=1S/C26H17Cl2F3N2O6/c1-12-23(37-22-11-15(4-7-19(22)28)36-13(2)25(34)35)18-10-16(38-26(29,30)31)5-8-20(18)33(12)24-17-6-3-14(27)9-21(17)39-32-24/h3-11,13H,1-2H3,(H,34,35)/t13-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	6	n/a	n/a	n/a	n/a	n/a	n/a
Merck Research Laboratories Curated by ChEMBL					Assay Description Displacement of [3H2]nTZD3 from human recombinant GST-fused PPARgamma expressed in Escherichia coli by scintillation proximity assay				J Med Chem 52: 3846-54 (2009) Article DOI: 10.1021/jm900097m BindingDB Entry DOI: 10.7270/Q2GF0TDR
					More data for this Ligand-Target Pair
Peroxisome proliferator-activated receptor (Homo sapiens (Human))	BDBM50166298 ((2S)-2-(4-chloro-3-(1-(6-chlorobenzo[d]isoxazol-3-...) Show SMILES C[C@H](Oc1ccc(Cl)c(Oc2c(C)n(-c3noc4cc(Cl)ccc34)c3ccc(OC(F)(F)F)cc23)c1)C(O)=O |r,wU:1.0,(28.69,2.15,;28.21,.68,;26.71,.36,;25.68,1.51,;26.15,2.97,;25.11,4.12,;23.61,3.79,;22.58,4.93,;23.14,2.33,;21.64,2.01,;21.16,.55,;22.08,-.71,;23.62,-.71,;21.17,-1.96,;21.64,-3.43,;20.75,-4.67,;21.65,-5.92,;23.11,-5.44,;24.44,-6.21,;25.77,-5.44,;27.1,-6.21,;25.76,-3.9,;24.44,-3.14,;23.11,-3.9,;19.69,-1.48,;18.35,-2.26,;17.02,-1.48,;17.02,.06,;15.69,.83,;15.69,2.37,;15.67,3.91,;17.23,2.38,;14.15,2.36,;18.35,.83,;19.69,.07,;24.17,1.18,;29.24,-.46,;30.75,-.14,;28.77,-1.93,)| Show InChI InChI=1S/C26H17Cl2F3N2O6/c1-12-23(37-22-11-15(4-7-19(22)28)36-13(2)25(34)35)18-10-16(38-26(29,30)31)5-8-20(18)33(12)24-17-6-3-14(27)9-21(17)39-32-24/h3-11,13H,1-2H3,(H,34,35)/t13-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	n/a	n/a	3	n/a	n/a	n/a	n/a
Merck Research Laboratories Curated by ChEMBL					Assay Description Maximal intrinsic response against peroxisome proliferator activated receptor gamma transactivation				Bioorg Med Chem Lett 15: 2437-40 (2005) Article DOI: 10.1016/j.bmcl.2005.03.092 BindingDB Entry DOI: 10.7270/Q2CF9PM8
					More data for this Ligand-Target Pair